Stonegate Capital Partners has updated its coverage on Burcon Nutrascience Corporation, highlighting the company's transition into commercial utilization with increased production of plant-based proteins. The report notes that demand for Burcon's pea, canola, and fava proteins is being driven by the growing market for GLP-1-related nutrition products, where high protein content and functional taste are critical for formulation.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.